SHARE:
Phil Frost
Companies that Frost owns a stake in
Miami (Amex-LTS)
Investment banking and brokerage
2006 revenue: $46.9 million
Frost’s role: Chairman, 31% stake
Dreams
Plantation (Amex-DRJ)
Manufacturer and seller of licensed sports and entertainment products
2007 revenue: $56 million
Frost’s role: 14% stake
Teva Pharmaceutical Industries
Israel (Nasdaq-TEVA),
Drug maker
2006 revenue: $8.4 billion
Frost’s role: Vice chairman, 2.7% stake
Protalix Biotherapeutics
Israel (Amex-PLX)
Biotech company focused on treatments for Gaucher and Fabry diseases and female infertility disorders
Revenue: As a development stage company, it had no revenue in 2006.
Frost’s role: Board member, 15% stake
Vector Group
Miami (NYSE-VGR)
Financier Bennett LeBow’s cigarette company
2006 revenue: $506 million
Frost’s role: 6.4% stake
Continucare
Miami (Amex-CNU)
Retail healthcare clinics and provider of primary care through employee doctors, nurses and physician assistants for two large HMOs
2006 revenue: $133 million
Frost’s role: Board member, 32% stake
Opko Health
Miami (Amex-OPK)
Developer of drugs and diagnostic equipment for eye disease
Revenue: As a development stage company, it has no revenue.
Frost’s role: Chairman/CEO, 15%-plus stake
Non-Invasive Monitoring Systems
North Bay Village, near Miami Beach
(OTCBB-NIMU.OB)
A company of University of Miami med school professor and inventor Marvin A. Sackner, developing non-invasive, drug-free therapies, particularly a vibrating gurneylike device to treat minor aches and pains
2006 revenue: $341,000
Frost’s role: 15.7% stake
Modigene
Vienna, Va.
(OTCBB-MODG.OB)
Seeks to develop longer-lasting versions of already approved proteins that treat illness
Revenue: As a development stage company, it has no revenue.
Frost’s role: 13% stake
Cellular Technical Services
Valley Stream, N.Y.
(OTCBB-CTSC.OB)
A shell company that Frost merged with privately held SafeStich and will rename SafeStich Medical Devices, based in Miami with R&D in Omaha. SafeStich develops endoscopic and minimally invasive surgery devices.
Revenue: None
Frost’s role: 31% stake
Peregrine Ventures
Israel (private)
Venture capital fund for early-stage investments in high-tech companies
Holdings: It has more than a dozen companies in its portfolio.
Frost’s role: General partner, investment committee member
Ideation Acquistion
Beverly Hills, Calif.,
(proposed Amex-IDI)
A blank-check company looking to acquire a digital media business
Cash: Proposes to raise $78.6 million
Frost’s role: Chairman, 11% stake after it goes public
Meanwhile:
Frost also is on the board at the University of Miami, the Smithsonian Institution and defense contractor Northrop Grumman and is co-vice chair of the American Stock Exchange.
